Table 2 Comparison of SyMRI parameters of TSC patients and healthy controls

BPV (ml)

1278

1125–1502

1202

1033–1476

.860

ICV (ml)

1400

1235–1599

1399

1176–1629

.705

WM (ml)

378

301–550

398

343–538

.561

GM (ml)

855

707–1012

821

727–996

.820

CSF (ml)

109

75–309

91

66–212

.561

MY (ml)

109

81–138

93

85–113

.118

Non-WM/GM/CSF (ml)

15

7.7–65

20

15–43

.035*

%Non/BPV

1.15

0.6–4.7

1.6

1.1–3.1

.049*

%MY/ICV

7.8

6.4–9.4

6.7

5.9–9

.05*

%MY/BPV

8.7

6.9–10

7.7

6.8–9.7

.035*

%Non/ICV

1.1

0.6–4.3

1.5

1–2.7

.050*

R NABP MyC

28.55

24.8–34.8

25.6

22–30

.035*

R NABP PD

66.9

62.8–69.4

68.9

66–71.2

.023*

L NABP MyCvol

0.18

0.10–0.20

0.16

0.14–0.19

.017*

L NABP MyC

28.5

24.6–32.3

26

23.5–29.9

.001*

L NABP PD

66.9

64–69

68.6

66–70

.001*

R Caudate MyC

7.2

4.5–8.7

5.35

2–7.3

.004*

R Caudate PD

81

79.8–82.7

82.2

80.8–86.7

.005*

L Caudate MyC

5.2

1–8.3

7.2

5.7–10

.004*

L Caudate PD

80.7

79.1–82

81.9

79.5–85.4

.023*

L Thalamus MyCvol

0.07

0.04–0.10

0.055

0.03–0.09

.009*

Pons MyCvol

0.09

0.07–0.12

0.07

0.06–0.09

.000*

Pons MYC

21.85

18–29

16.7

13.6–20.4

.000*

Pons PD

70.95

66.1–74

74.7

69.4–76.7

.002*